The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Frequency of cisplatin administration in patients presenting with advanced urothelial carcinoma in the community.
Guru Sonpavde
No relevant relationships to disclose
Deidre Watson
No relevant relationships to disclose
Marcia Tourtellott
No relevant relationships to disclose
Erica Higgins
No relevant relationships to disclose
Charles Lance Cowey
No relevant relationships to disclose
Beth A. Hellerstedt
No relevant relationships to disclose
Thomas E. Hutson
No relevant relationships to disclose
Feng Zhan
No relevant relationships to disclose
Nicholas J. Vogelzang
No relevant relationships to disclose